UFP Technologies reports record Q2 2026: sales $174.0M (+15.1% YoY), net income $20.9M (+21.4%)

Filed August 3, 2026 · Period ending August 3, 2026 · ~1 min read

Key Changes

• high

  Net sales reached $174.0M in Q2 2026, up 15.1% from $151.2M in Q2 2025, with net income of $20.9M (up 21.4% from $17.2M). GAAP diluted EPS was $2.68 versus $2.21 prior year; adjusted EPS was $2.92 versus $2.50.

  Exhibit 99.1 view on EDGAR →
• medium

  Gross margin expanded 50 basis points to 29.3% from 28.8% year-over-year, despite near-term mix and margin pressure in U.S. operations from ongoing Dominican Republic capacity investments.

  Exhibit 99.1 view on EDGAR →
• medium

  Top five customers grew 14.7% in Q2, while the remainder of MedTech business grew 19.7%; non-medical business was flat, indicating broad-based MedTech growth beyond largest accounts.

  Exhibit 99.1 view on EDGAR →